• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:赵德华,曾卫强,陈静,贾霖,韩建军,龙小庆,王继生.肿瘤患者围化疗期的药学监护[J].中国现代应用药学,2017,34(3):427-431.
ZHAO Dehua,ZENG Weiqiang,CHEN Jing,JIA Lin,HAN Jianjun,LONG Xiaoqing,WANG Jisheng.Peri-chemotherapy Pharmaceutical Monitoring on Cancer Patients[J].Chin J Mod Appl Pharm(中国现代应用药学),2017,34(3):427-431.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2121次   下载 2984 本文二维码信息
码上扫一扫!
分享到: 微信 更多
肿瘤患者围化疗期的药学监护
赵德华1, 曾卫强2, 陈静1, 贾霖1, 韩建军1, 龙小庆1, 王继生1
1.绵阳市第三人民医院(四川省精神卫生中心)临床药学科, 四川 绵阳 621000;2.广东省人民医院药学部, 广州 510080
摘要:
目的 探讨临床药师参与肿瘤患者围化疗期的药学监护。方法 通过对给药顺序、预处理、避光输注、剂量调整、不良反应及相应措施等进行归纳和整理,阐述临床药师对肿瘤患者进行的围化疗期药学监护。结果 利用围化疗期的药学监护,可实现对肿瘤患者治疗的全程管理,降低药物的不良反应;提高患者的依从性。结论 围化疗期的药学监护是临床药师参与肿瘤患者治疗的重要切入点,能为临床提供个体化的给药方案,从而积极发挥临床药师在肿瘤患者治疗中的作用。
关键词:  临床药师  围化疗期  药学监护  不良反应  依从性
DOI:10.13748/j.cnki.issn1007-7693.2017.03.029
分类号:
基金项目:
Peri-chemotherapy Pharmaceutical Monitoring on Cancer Patients
ZHAO Dehua1, ZENG Weiqiang2, CHEN Jing1, JIA Lin1, HAN Jianjun1, LONG Xiaoqing1, WANG Jisheng1
1.Sichuan Mental Health Center, Mianyang 621000, China;2.Department of Pharmacy, Guangdong General Hospital, Guangzhou 510080, China
Abstract:
OBJECTIVE To investigate the peri-chemotherapy pharmaceutical monitoring on cancer patients taken by clinical pharmacists. METHODS To expatiate the clinical pharmacists take peri-chemotherapy pharmaceutical monitoring on cancer patients by summarizing and organizing the sequence of administration, drug pretreatment, drug lucifugal infusion, dose adjustment, toxicities and measures. RESULTS Using the peri-chemotherapy pharmaceutical monitoring, clinical pharmacists could take the whole management of the treatment for cancer patients, reduced the toxicity and improved the compliance of patients. CONCLUSION Peri-chemotherapy monitoring is a good point for clinical pharmacists to involve in patients' treatment which can provide individualized treatment to clinic and patients, thus clinical pharmacists can play a positive role in the threatment of caner patients.
Key words:  clinical pharmacists  peri-chemotherapy  pharmaceutical monitoring  adverse reactions  compliance
扫一扫关注本刊微信